Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 5 studies | 27% ± 7% | |
epithelial cell | 3 studies | 30% ± 9% | |
type I pneumocyte | 3 studies | 18% ± 2% | |
interneuron | 3 studies | 31% ± 18% |
Insufficient scRNA-seq data for expression of OVOL2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 296.74 | 328 / 328 | 94% | 15.28 | 168 / 178 |
thymus | 100% | 470.73 | 650 / 653 | 91% | 11.28 | 548 / 605 |
prostate | 90% | 562.37 | 220 / 245 | 100% | 19.57 | 501 / 502 |
lung | 87% | 214.02 | 504 / 578 | 93% | 14.09 | 1079 / 1155 |
stomach | 75% | 498.25 | 270 / 359 | 96% | 19.03 | 274 / 286 |
breast | 59% | 405.23 | 272 / 459 | 99% | 24.33 | 1104 / 1118 |
intestine | 45% | 237.14 | 434 / 966 | 98% | 20.10 | 517 / 527 |
bladder | 43% | 131.81 | 9 / 21 | 91% | 17.34 | 461 / 504 |
esophagus | 39% | 198.32 | 560 / 1445 | 94% | 15.97 | 172 / 183 |
ureter | 0% | 0 | 0 / 0 | 100% | 13.08 | 1 / 1 |
ovary | 1% | 0.50 | 1 / 180 | 98% | 25.39 | 422 / 430 |
uterus | 8% | 22.41 | 14 / 170 | 83% | 17.01 | 379 / 459 |
tonsil | 0% | 0 | 0 / 0 | 89% | 12.87 | 40 / 45 |
kidney | 79% | 135.08 | 70 / 89 | 7% | 0.46 | 62 / 901 |
skin | 72% | 500.95 | 1302 / 1809 | 1% | 0.12 | 6 / 472 |
lymph node | 0% | 0 | 0 / 0 | 17% | 1.32 | 5 / 29 |
brain | 11% | 13.22 | 296 / 2642 | 0% | 0.01 | 1 / 705 |
liver | 0% | 0 | 0 / 226 | 11% | 1.49 | 44 / 406 |
adipose | 1% | 2.73 | 14 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 0% | 0 | 0 / 258 | 0% | 0.10 | 1 / 230 |
peripheral blood | 0% | 0.35 | 2 / 929 | 0% | 0 | 0 / 0 |
heart | 0% | 0.20 | 1 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0.28 | 1 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
GO_0001525 | Biological process | angiogenesis |
GO_0008283 | Biological process | cell population proliferation |
GO_0060392 | Biological process | negative regulation of SMAD protein signal transduction |
GO_0030512 | Biological process | negative regulation of transforming growth factor beta receptor signaling pathway |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0001755 | Biological process | neural crest cell migration |
GO_0001947 | Biological process | heart looping |
GO_0060347 | Biological process | heart trabecula formation |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0009913 | Biological process | epidermal cell differentiation |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_2000647 | Biological process | negative regulation of stem cell proliferation |
GO_0009953 | Biological process | dorsal/ventral pattern formation |
GO_0060214 | Biological process | endocardium formation |
GO_0010719 | Biological process | negative regulation of epithelial to mesenchymal transition |
GO_0048557 | Biological process | embryonic digestive tract morphogenesis |
GO_0060716 | Biological process | labyrinthine layer blood vessel development |
GO_0001842 | Biological process | neural fold formation |
GO_0010837 | Biological process | regulation of keratinocyte proliferation |
GO_0045618 | Biological process | positive regulation of keratinocyte differentiation |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0003682 | Molecular function | chromatin binding |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | OVOL2 |
Protein name | Transcription factor Ovo-like 2 (hOvo2) (Zinc finger protein 339) |
Synonyms | ZNF339 |
Description | FUNCTION: Zinc-finger transcription repressor factor . Plays a critical role in maintaining the identity of epithelial lineages by suppressing epithelial-to mesenchymal transition (EMT) mainly through the repression of ZEB1, an EMT inducer (By similarity). Positively regulates neuronal differentiation (By similarity). Suppresses cell cycling and terminal differentiation of keratinocytes by directly repressing MYC and NOTCH1 . Important for the correct development of primordial germ cells in embryos (By similarity). Plays dual functions in thermogenesis and adipogenesis to maintain energy balance. Essential for brown/beige adipose tissue-mediated thermogenesis, is necessary for the development of brown adipocytes. In white adipose tissues, limits adipogenesis by blocking CEBPA binding to its transcriptional targets and inhibiting its transcription factor activity (By similarity). . |
Accessions | Q9BRP0 ENST00000278780.7 [Q9BRP0-1] |